| | |
| |
| | | |
|
Brennan & Kavouklis, P.A. Newsletter Archive |
|
|
SPRING 2006 ISSUE
DRUG SAFETY ALERT
Brennan & Kavouklis, P.A. Injury
Law Alert Newsletter
Subscribe Un-Subscribe
The U.S. Food and Drug Administration (FDA) has issued a safety
alert on Avandia, a drug used to treat type 2 diabetes. Several
clinical trials have shown that there is a significant increase
in the risk of heart attack and heart related deaths in patients
taking Avandia.
The drug is manufactured and marketed by GlaxoSmithKline. It
was approved by the FDA in 1999, and more than one million people
have taken the drug in the U.S. alone. Avandia has been heavily
promoted to consumers, and some believe that GlaxoSmithKline
should have known of the potential risks and warned those taking
the drug.
According to the FDA, “Patients who are taking Avandia,
especially those who are known to have underlying heart disease
or who are at high risk of heart attack should talk to their
doctor about this new information as they evaluate the available
treatment options for their type 2 diabetes.” If you or
a loved one has suffered a heart problem that you believe is
related to Avandia, be sure to contact our office.
WE APPRECIATE YOU
Thank you for choosing our firm for your legal needs. We hope
that you will continue to count on us when you need legal help.
We are just a phone call away.
We also appreciate the trust that you have placed in us by referring
your friends, family, and associates to us for legal services.
Thanks! We never charge a fee on injury cases unless we recover
money for you…its that simple!
Brennan & Kavouklis, P.A., Pa
Injury Attorneys
If you are interested in receiving help on your potential
case, please click
here for free (secure online) Case Evaluation. Any initial
consultation with Brennan & Kavouklis, P.A. is free. For more information,
contact us at 813-254-7770, or by e-mail
|